comparemela.com

Latest Breaking News On - Hedge funds weigh in on inovio pharmaceuticals - Page 1 : comparemela.com

Inovio Pharmaceuticals (NASDAQ:INO) Coverage Initiated by Analysts at StockNews com

Equities research analysts at StockNews.com started coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) in a research report issued on Tuesday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Price Performance Shares of NASDAQ INO opened at $0.38 on Tuesday. The stock has a market capitalization of […]

Inovio Pharmaceuticals (NASDAQ:INO) Research Coverage Started at StockNews com

StockNews.com began coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a report released on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Trading Down 2.1 % NASDAQ:INO opened at $0.40 on Friday. The firm has a market capitalization of $109.58 million, a PE ratio of -0.64 […]

Inovio Pharmaceuticals (NASDAQ:INO) Receives New Coverage from Analysts at StockNews com

StockNews.com assumed coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a research report released on Saturday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Stock Performance Shares of NASDAQ:INO opened at $0.42 on Friday. The stock has a fifty day simple moving average of $0.41 and […]

Inovio Pharmaceuticals (NASDAQ:INO) Earns Sell Rating from Analysts at StockNews com

StockNews.com initiated coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a report issued on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Stock Performance INO stock opened at $0.39 on Monday. The stock has a market cap of $104.55 million, a P/E ratio of -0.60 and […]

Inovio Pharmaceuticals (NASDAQ:INO) Now Covered by StockNews com

StockNews.com assumed coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Price Performance Shares of Inovio Pharmaceuticals stock opened at $0.40 on Monday. The business has a 50-day simple moving average […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.